IMID patients have unique behavioral, preventive, and therapeutic care requirements. Due to the complexity of care, there is a large degree of segmentation and fragmentation of management across healthcare systems and amongst multiple providers. This “siloed” approach often falls short of seamless, efficient, high-quality patient-centered care. To address the rising costs and fragmentation of chronic disease management, population-based healthcare has emerged as a new concept with an emphasis on reward for value, not volume. One such example of population-based healthcare include patient-centered medical homes (PCMH). This concept relies on the development of new payment models and shifts the risk to the providers. The specialty medical home (SMH) is an example of a new model of care. The SMH is constructed to align incentives and provide up-front resources to optimally manage a population of patients with IMIDS -- including treatment of their inflammatory disease, coexisting pain, and psychological issues, among others.